Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN84,3584,380,39
Msft1,58
Nokia4,3894,48-0,27
IBM1,50
Mercedes-Benz Group AG50,1950,21-1,01
PFE0,24
04.07.2025 18:00:42
Indexy online
AD Index online
select
AD Index online
 

  • 03.07.2025 23:00:00
iRhythm Technolg Rg (NASDAQ Cons)
Závěr k 3.7.2025 Změna (%) Změna (USD) Objem obchodů (ks)
142,47 -0,22 -0,31 206 877
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 06.07.2025
Popis společnosti
Obecné informace
Název společnostiIrhythm Technologies Inc
TickerIRTC
Kmenové akcie:Ordinary Shares
RICIRTC.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 31.12.2024 2 000
Akcie v oběhu k 24.04.2025 31 925 267
MěnaUSD
Kontaktní informace
Ulice699 8th Street, Suite 600
MěstoSAN FRANCISCO
PSČ94103
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon14 156 325 700
Fax13026555049

Business Summary: iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Irhythm Technologies Inc revenues increased 20% to $158.7M. Net loss decreased 33% to $30.7M. Revenues reflect Healthcare Institutions segment increase of 36% to $26.7M, Centers for Medicare & Medicaid segment increase of 20% to $38.1M. Lower net loss reflects Loss on extinguishment of debt decrease from $7.6M (expense) to $0K.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Medical Monitoring Systems
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICSGeneral Medical and Surgical Hospitals
NAICS2007General Medical and Surgical Hospitals
NAICS1997General Medical and Surgical Hospitals
SICGeneral Med'L/surgical Hospitals



  • Poslední aktualizace: 06.07.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorQuentin Blackford4604.10.202104.10.2021
Chief Financial OfficerDaniel Wilson4331.08.2024
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical OfficerMinang Turakhia5128.04.2022
Executive Vice President, Chief Risk OfficerSumi Shrishrimal46
Executive Vice President - Business OperationsMervin Smith49
Chief Business Officer, Chief Legal OfficerPatrick Murphy4601.01.2021
Chief Commercial OfficerChad Patterson4325.07.202225.07.2022